The first 100 days: life sciences in the Trump administration

Webinar

May 17, 2017 | 12:00 pm - 1:00 pm CT | Webinar | Accreditation 1.00 CLE

Join Norton Rose Fulbright as we discuss the impact of the first 100 days of the Trump administration on the life sciences sector – where we are and where we are headed.

Topics will include:

  • What should the industry expect from Dr. Scott Gottlieb, the new commissioner of the Food and Drug Administration (FDA)?
  • Speed of product approvals
  • Change in basis of approvals
  • User fee increases
  • Off-label promotion
  • Drug pricing
  • How will the FDA implement the Executive Order to reduce regulations?
  • What is the outlook for the FDA's implementation of the 21st Century Cures Act?
  • What will change in government's support and oversight of scientific research?

Download the presentation: The first 100 days: life sciences in the Trump administration

Speakers

Michael Lee Koon

Michael Lee Koon

Partner, Norton Rose Fulbright US LLP

Agenda

10:00 am - 11:00 am PDT
11:00 am - 12:00 pm MDT
12:00 pm - 1:00 pm CDT
1:00 pm - 2:00 pm EDT
6:00 pm - 7:00 pm BST

Subscribe and stay up to date with the latest legal news, information and events... Register now